For: | Zhang W, Wang QZ, Chen XW, Zhong HS, Zhang XT, Chen XD, Xu K. Budd-Chiari syndrome in China: A 30-year retrospective study on survival from a single center. World J Gastroenterol 2018; 24(10): 1134-1143 [PMID: 29563757 DOI: 10.3748/wjg.v24.i10.1134] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v24/i10/1134.htm |
Number | Citing Articles |
1 |
Fredrik Åberg, Rupesh Rajani, Axel Wester, Linnea Widman, Hannes Hagström. Three-fold Increased Risk of Death in Budd-Chiari Syndrome Compared to Matched Controls: A Population-based Cohort Study. Clinical Gastroenterology and Hepatology 2023; 21(4): 995 doi: 10.1016/j.cgh.2022.04.032
|
2 |
Mikal Obed, Mohammad Ibrahim Othman, Saeb Hammoudi, Mahmoud Abdelkader Chattab, Anwar Jarrad, Abdalla Bashir, Aiman Obed. Living Donor Liver Transplant in Patients With Budd-Chiari Syndrome: A Single-Center Experience at Our University Hospital. Experimental and Clinical Transplantation 2020; 18(7): 796 doi: 10.6002/ect.2020.0331
|
3 |
|
4 |
Long-Term Outcomes of Endovascular Interventions in More than 500 patients with Budd–Chiari Syndrome. Journal of Vascular and Interventional Radiology 2021; 32(1): 61 doi: 10.1016/j.jvir.2020.08.035
|
5 |
Peter Franz Klein-Weigel, Saban Elitok, Andreas Ruttloff, Sabine Reinhold, Jessica Nielitz, Julia Steindl, Philippe Lutfi, Lars Rehmenklau-Bremer, Birgit Hillner, Heiko Fuchs, Christian Wrase, Thomas Herold, Lukas Beyer. Inferior vena cava-syndrome. Vasa 2021; 50(4): 250 doi: 10.1024/0301-1526/a000919
|
6 |
Peng‐Xu Ding, Xin‐Wei Han, Chao Liu, Yan Zhang, An‐Ling Cheng, Yan Wu, Xiao‐Xue Liang, Xue‐Mei Gao, Edward Wolfgang Lee. Long‐term outcomes of individualized treatment strategy in treatment of type I Budd‐Chiari syndrome in 456 patients. Liver International 2019; 39(8): 1577 doi: 10.1111/liv.14114
|
7 |
Kehui Liu, Yezhou Ding, Yumin Xu, Weiliang Tang, Mingyang Feng, Yunye Liu, Shisan Bao, Hui Wang. AL amyloidosis with primary presentation of multiple serous cavity effusion and severe cholestasis: a case report and review of literature. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02201-4
|
8 |
A. Sharma, S. N. Keshava, A. Eapen, E. Elias, C. E. Eapen. An Update on the Management of Budd–Chiari Syndrome. Digestive Diseases and Sciences 2021; 66(6): 1780 doi: 10.1007/s10620-020-06485-y
|
9 |
Ting-Ting Li, Yi-Fan Wu, Fu-Quan Liu, Fu-Liang He. Hepatic amyloidosis leading to hepatic venular occlusive disease and Budd-Chiari syndrome: A case report. World Journal of Clinical Cases 2019; 7(20): 3282-3288 doi: 10.12998/wjcc.v7.i20.3282
|
10 |
Kang-Shuai Li, Sen Guo, Yu-Xin Chen, Zong-Li Zhang. Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1075685
|
11 |
Chinmay Bhimaji Kulkarni, Srikanth Moorthy, Sreekumar Karumathil Pullara, Nirmal Kumar Prabhu, Ramiah Rajesh Kannan, Puthukudiyil Kader Nazar. Budd-Chiari syndrome managed with percutaneous recanalization: Long-term outcome and comparison with medical therapy. International Journal of Gastrointestinal Intervention 2019; 8(2): 74 doi: 10.18528/ijgii180001
|
12 |
Mihnea-Alexandru Găman, Matei-Alexandru Cozma, Muhammad Romail Manan, Bahadar S Srichawla, Arkadeep Dhali, Sajjad Ali, Ahmed Nahian, Andrew C Elton, L V Simhachalam Kutikuppala, Richard Christian Suteja, Sebastian Diebel, Amelia Maria Găman, Camelia Cristina Diaconu. Budd-Chiari syndrome in myeloproliferative neoplasms: A review of literature. World Journal of Clinical Oncology 2023; 14(3): 99-116 doi: 10.5306/wjco.v14.i3.99
|
13 |
Alberto Zanetto, Valentina Cossiga, Sarah Shalaby, Maria Guarino, Federica Invernizzi, Lucia Lapenna, Chiara Becchetti, Filomena Morisco, Maria Cristina Morelli, Manuela Merli, Pierluigi Toniutto, Patrizia Burra. Vascular liver diseases: A sex-oriented analysis of the literature. Digestive and Liver Disease 2023; 55(2): 178 doi: 10.1016/j.dld.2022.07.005
|
14 |
Wei Zhang, Yu-Long Tian, Qiao-Zheng Wang, Xiao-Wei Chen, Qi-Yang Li, Jin-Hang Han, Xu-Dong Chen, Ke Xu. Restenosis after recanalization for Budd-Chiari syndrome: Management and long-term results of 60 patients. World Journal of Clinical Cases 2020; 8(14): 2930-2941 doi: 10.12998/wjcc.v8.i14.2930
|
15 |
Gauri Mukhiya, Xueliang Zhou, Xinwei Han, Dechao Jiao, Gaurab Pokhrel, Yahua Li, Sita Pokhrel. Evaluation of outcome from endovascular therapy for Budd-Chiari syndrome: a systematic review and meta-analysis. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-20399-x
|